May 18, 2007 12:00 AM
Have you suffered a stroke, a heart attack or experienced blot clots after wearing the Ortho Evra patch for birth control? If so, you may have a claim that is compensable. Here are some of the facts to consider.
May 16, 2007 12:00 AM
A Pfizer Inc. unit failed to properly warn a New Jersey woman about the cancer risk of its hormone- replacement drug Provera and should pay $1.5 million in damages,
May 14, 2007 12:00 AM
The Senate Health Committee passed the Pharmaceutical Drug Information and Safety Act, which will require pharmaceutical companies to make the clinical studies they conduct publicly available.
May 14, 2007 12:00 AM
The number of American women getting mammograms fell in the early part of the 21st century, reversing a trend that helped slash deaths from breast cancer.
May 14, 2007 12:00 AM
The Connecticut-based maker of the powerful painkiller OxyContin and three of its current and former executives pleaded guilty to misleading the public about the drug's risk of addiction.
May 14, 2007 12:00 AM
Prescription drugs would be monitored more closely for side effects under legislation the Senate approved Wednesday aimed at staving off future high-profile drug withdrawals.
May 11, 2007 12:00 AM
National Women's Health Week is May 13-19, and as a physician and a woman, I urge menopause-aged women to ask their doctors about alternatives to hormone-replacement drugs like Premarin and Prempro.
May 10, 2007 12:00 AM
New evidence reveals the potential for very serious harm from the bisphosphonates Zoledronate (Zometa) and Fosamax.
May 8, 2007 12:00 AM
Fosamax, the Merck brand name for alendronate, is now used by an estimated 1.8 million American women. In a letter to the medical journal, Cummings reported evidence of the heart problem found in a recent review of a 1997 Merck-sponsored study of postmenopausal women on Fosamax.
May 3, 2007 12:00 AM
Sales of Wyeth's Premarin and Prempro hormones evaporated following a U.S. study in 2002 linking the pills to breast cancer, heart attacks and strokes.